Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Sold by Two Sigma Investments LP

Two Sigma Investments LP cut its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 56.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,255 shares of the company's stock after selling 42,024 shares during the quarter. Two Sigma Investments LP owned about 0.08% of Viemed Healthcare worth $259,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in VMD. Corton Capital Inc. purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $82,000. EntryPoint Capital LLC purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $92,000. Prudential Financial Inc. purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $93,000. Man Group plc purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $95,000. Finally, Oxford Asset Management LLP purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $98,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Down 1.9%

Shares of NASDAQ VMD traded down $0.13 during midday trading on Friday, reaching $6.65. 102,829 shares of the company's stock were exchanged, compared to its average volume of 140,863. Viemed Healthcare, Inc. has a 52-week low of $6.14 and a 52-week high of $9.81. The stock has a market capitalization of $262.83 million, a PE ratio of 24.63 and a beta of 1.38. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The business's fifty day moving average price is $6.76 and its two-hundred day moving average price is $7.53.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.